Foley Partner Antoinette Konski authored an article that appeared in the September 2011 issue of BioProcess International titled “Generic Biologics.” Konski reviews several key provisions of various regulatory pathways for generic biologics in the United States, China, India and throughout Europe, and discusses how these pathways could support biosimilar manufacturing.
Click here to read the complete article.
Autor(es)
Informações relacionadas
December 10, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Climate and Resiliency (EX) Task Force
The mission of the Climate and Resiliency (EX) Task Force is to serve as the coordinating NAIC body for discussion and engagement on…
December 9, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Reinsurance (E) Task Force Discusses Implementation of Actuarial Guideline LV for Testing Adequacy of Reserves in Life Reinsurance
On December 9, 2025, the Reinsurance (E) Task Force, which reports to the Financial Condition (E) Committee, met to discuss, among other…
December 9, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Third-Party Data and Models (H) Working Group Exposes Risk-Based Regulatory Framework for Third-Party Data and Model Vendors
On December 9, 2025, the Third-Party Data and Models (H) Working Group, which reports to the Innovation Cybersecurity and Technology (H)…